Thromb Haemost. 1979 Dec 21;42(4):1073-114.
In collaborative experiments in 199 laboratories, nine commercial thromboplastins, four thromboplastins held by the National Institute for Biological Standards and Control (NIBS & C), London and the British Comparative Thromboplastin were tested on fresh normal and coumarin plasmas, and on three series of freeze-dried plasmas. One of these was made from coumarin plasmas and the other two were prepared from normal plasmas; in each series, one plasma was normal and the other two represented different degrees of coumarin defect. Each thromboplastin was calibrated against NIBS & C rabbit brain 70/178, from the slope of the line joining the origin to the point of intersection of the mean ratios of coumarin/normal prothrombin times when the ratios obtained with the two thromboplastins on the same fresh plasmas were plotted against each other. From previous evidence, the slopes were calculated which would have been obtained against the NIBS & C "research standard" thromboplastin 67/40, and termed the "calibration constant" of each thromboplastin. Values obtained from the freeze-dried coumarin plasmas gave generally similar results to those from fresh plasmas for all thromboplastins, whereas values from the artificial plasmas agreed with those from fresh plasmas only when similar thromboplastins were being compared. Taking into account the slopes of the calibration lines and the variation between laboratories, precision in obtaining a patient's prothrombin time was similar for all thromboplastins.
在199个实验室开展的合作实验中,对9种市售凝血活酶、伦敦国家生物标准与控制研究所(NIBS&C)持有的4种凝血活酶以及英国比较凝血活酶,在新鲜正常血浆和香豆素血浆以及三组冻干血浆上进行了测试。其中一组冻干血浆由香豆素血浆制成,另外两组由正常血浆制备;在每组中,一份血浆是正常的,另外两份代表不同程度的香豆素缺陷。每种凝血活酶均以NIBS&C兔脑70/178为对照进行校准,方法是将两种凝血活酶在同一新鲜血浆上获得的香豆素/正常凝血酶原时间的平均比值相互绘制,然后从连接原点到交点的直线斜率进行校准。根据先前的证据,计算出相对于NIBS&C“研究标准”凝血活酶67/40本应获得的斜率,并将其称为每种凝血活酶的“校准常数”。对于所有凝血活酶而言,从冻干香豆素血浆获得的值与从新鲜血浆获得的值总体上相似,而仅在比较相似的凝血活酶时,人工血浆获得的值才与新鲜血浆获得的值一致。考虑到校准线的斜率和各实验室之间的差异,所有凝血活酶在获取患者凝血酶原时间方面的精密度相似。